In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Sutro Biopharma (STRO – Research Report), with a price target of $17.00. Discover outperforming stocks ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Sutro Biopharma (STRO – Research Report) today and set a price target of $11.00. The company’s shares closed ...

Another free option comes in the form of VRT, which is a free-to-air public broadcaster in cycling-mad Belgium. The Dendermonde World Cup will go out on TV on VRT 1 and online on the VRT Max ...

STRO's valuation remains compelling despite recent market hits, with optimism for a turnaround driven by late-stage clinical trials and strong pipeline potential. Luveltamab tazevibulin shows ...

Welcome to the Year in Review, where we’re rewinding the clock on an entire year’s worth of coverage to highlight the notable and under-the-radar product releases that crossed our desk in 2024. Here’s ...